NAD+ in Parkinson’s: A Trial Result Nobody Saw Coming
A year-long trial tested NAD+ booster nicotinamide riboside in 410 people with early Parkinson disease — and placebo won. What supplement buyers should know.
October 9, 2026
Cinnamon Plus Workouts: What 6 Weeks Did for 48 Cadets
48 cadets did Tabata, took cinnamon, or both for 6 weeks. The combo group got the biggest fat-burning hormone boost — even the non-trainers lost fat.
October 8, 2026
Omega-3s and AFib: The 1,500 mg Line That Changes Everything
A new 35-trial analysis says omega-3s only raise AFib risk above 1,500 mg/day in high-risk people. Here is the dose line that matters for your fish oil habit.
October 7, 2026
1,000 mg of Vitamin C a Day: What a New Trial Really Found
In a new trial, 109 people took 1,000 mg of vitamin C daily for a year. The main goal wasn’t met — but an unexpected signal caught scientists’ attention.
October 6, 2026
